The city of Columbus, Georgia, currently has 2 active clinical trials seeking participants for Type 1 Diabetes research studies.
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Recruiting
This is a multicenter, randomized, double-blind, parallel, placebo-controlled Phase 3, 2-arm study for treatment. The purpose of this study is to measure change in glycemic control and prandial insulin independency over 52 weeks with teplizumab compared with placebo, both administered by intravenous (IV) infusion, in participants with recently diagnosed Stage 3 type 1 diabetes (T1D) aged 1 to 25 years, on standard insulin therapy.
Gender:
ALL
Ages:
Between 1 year and 25 years
Trial Updated:
08/08/2025
Locations: IACT Health - Columbus - Talbotton Road- Site Number : 8400003, Columbus, Georgia
Conditions: Type 1 Diabetes Mellitus
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Recruiting
This is a Phase 3 trial of cadisegliatin as adjunctive therapy to insulin in participants with Type 1 Diabetes Mellitus.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/15/2025
Locations: Centricity Research - Columbus, Columbus, Georgia
Conditions: Diabetes Mellitus, Type 1